Impact of body composition on outcomes from anti-PD1 +/- anti-CTLA-4 treatment in melanoma.
Arissa C YoungHenry T QuachHaocan SongElizabeth J DavisJavid J MoslehiFei YeGrant R WilliamsDouglas B JohnsonPublished in: Journal for immunotherapy of cancer (2021)
Body composition analysis identified several features that correlated with improved clinical outcomes, although the associations were modest. As with other studies, we identified sex-specific associations that warrant further study.